Buy SBI Life Insurance; target of Rs 1050: Emkay Global Financial

Emkay Global Financial is bullish on SBI Life Insurance has recommended buy rating on the stock with a target price of Rs 1050 in its research report dated January 22, 2021.

Broker Research
January 25, 2021 / 05:00 PM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Emkay Global Financial's report on SBI Life Insurance


SBIL reported Value of New Business (VNB) growth of ~12.9% yoy to Rs7bn with further improvement in VNB Margins. AUM crossed Rs2tn with private market leadership in NBP at ~23.7% market share. Renewal Premium grew 27% with 13M persistency at 86.2%. VNB margins improved by ~170bps yoy (+120bps qoq) to ~20% in Q3FY20, better than our and Street expectations. With a gradual decline in ULIPs, the overall margin profile should witness steady growth, aided by a rise in single premium policies. Management remains firm about the rising share of Protection plans through increasing focus on credit protection. However, like IPRU, SBIL also depends heavily on bancasurance (~64% of distribution by SBI), which could trigger steady growth for ULIPs in H2FY20 due to stabilizing trends in the equity market.


Outlook


We retain our estimates with VNB margin improving to ~23% by FY23E and 20.4% CAGR in absolute VNB to Rs35bn. Maintain Buy/OW stance in Insurance EAP, with a TP of Rs1,050 (Rs1,006 earlier), corresponding to 2.5x P/Mar’23 EV. We continue to like the stock based on improving profitability and attractive risk-reward.


For all recommendations report, click here


Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Broker Research
TAGS: #Buy #Emkay Global Financial #Recommendations #SBI Life Insurance
first published: Jan 25, 2021 05:00 pm